We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
China Evoline | LSE:CEVO | London | Ordinary Share | GB00B3N52J55 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 50.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCEVO RNS Number : 5060K China Evoline PLC 21 April 2010 China Evoline PLC Suspension of Ordinary Shares 21 April 2010 As detailed in the interim results announced on 15 February 2010, under the AIM Rules the Company was required to make a substantial acquisition (which would be regarded as a reverse takeover) by 21 April 2010, being twelve months from the date of the 2009 AGM, or trading in the Company's ordinary shares would be suspended. Whilst the Directors have evaluated a number of potential investment opportunities, none have been suitable to be put to shareholders for approval. As a result, trading in the Company's ordinary shares has been suspended with immediate effect. If no transaction is achieved by the Company within a further six months, being by 21 October 2010, the London Stock Exchange will cancel admission of the shares on AIM. The Directors are pursuing a number of investment opportunities which they are hopeful will result in an acquisition being completed by October 2010. If the Company successfully identifies a suitable investment opportunity, the ability to continue as a going concern will depend on being able to raise the necessary finance in order to fund the appropriate due diligence and purchase price consideration and being able to successfully integrate the target into the Group so as to generate cash in the future. If the Company fails to secure any additional finance, the Company will be unable to continue as a going concern as it will have insufficient funds to trade after twelve months. The ability of the Company to continue as a going concern is dependent on continued financial support of the majority shareholder. For further information please contact: China Evoline plc Frank Lewis, Chairman +44 (0)7775 504 313 Fairfax I.S. PLC Nominated Adviser and Broker Katy Birkin/Laura Littley +44 (0)207 598 5368 This information is provided by RNS The company news service from the London Stock Exchange END SRSURVVRRKASUAR
1 Year China Evoline Chart |
1 Month China Evoline Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions